Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal Cancer

with No hi ha comentaris
  • Napolitano, S., Woods, M., Lee, H. M., De Falco, V., Martini, G., Della Corte, C. M., Martinelli, E., Famiglietti, V., Ciardiello, D., Anderson, A., Fowlkes, N. W., Villareal, O. E., Sorokin, A., Kanikarla, P., Coker, O., Morris, V., Altucci, L., Tabernero, J., Troiani, T., … Kopetz, S. (2023). Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal Cancer. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 29(12), 2299-2309. https://doi.org/10.1158/1078-0432.CCR-22-3894

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *